Skip to content

Bupivacain injection effect in orbicullaris muscle in partial fascial nerve palsy

Clinical effect of Bupivacain injection in orbicularis oculi muscle in patient with facial nerve palsy.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT2013022712637N1
Enrollment
15
Registered
2013-04-18
Start date
2011-12-22
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Partial peripheral facial nerve palsy. Disorder of peripheral nervous system NOS

Interventions

Four cc bupivacaine 0.75 was injected in pre tarsal and pre septal part of orbicullaris muscle. Two and 4 weeks later this injecion was done again..
Treatment - Drugs
Four cc bupivacaine 0.75 was injected in pre tarsal and pre septal part of orbicullaris muscle. Two and 4 weeks later this injecion was done again.

Sponsors

Ophthalmology research center of Tehran university of medical science
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion criterion: patients with partial facial nerve palsy and ocular involvement who referred to us at least 12 weeks after the onset of symptoms. Exclusion criteria: complete facial nerve palsy; traumatic palsy; corneal ulcer; immediate need to surgical intervention; third and forth cranial nerve palsy and any type of strabismus.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Orbicularis muscle function. Timepoint: One month, 3 months and 6 months after first exam. Method of measurement: Questionnaire.

Secondary

MeasureTime frame
Palpebral fissure hight in open and close eye. Timepoint: 1, 3 and 6 months after first exam. Method of measurement: milimeter.;Marginal reflex distance 1 and 2. Timepoint: 1, 3 and 6 months after first exam. Method of measurement: milimeter.;Scleral show in close eye. Timepoint: 1, 3 and 6 months after first exam. Method of measurement: milimeter.;Corneal exposure in closed eye. Timepoint: 1, 3 and 6 months after first exam. Method of measurement: milimeter.;Epiphora and its severity. Timepoint: 1, 3 and 6 months after first exam. Method of measurement: Subjective.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahla Shadravan

Tehran University of Medica, Farabi eye hospital

mshadravan.oph@gmail.com+98 21 5540 0003

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026